FDA’s plan to boost cheaper copycat drugs could stall at the patent office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis,…
580K bottles of blood pressure medications recalled due to cancer-causing chemical – WSB-TV Channel 2
More than half a million bottles of a popular blood pressure medication have been recalled because they contain…
FDA announces plans to relax rules about copycat drugs
The U.S. Food and Drug Administration announced Wednesday that it will relax certain rules for approving low-cost versions…
580K bottles of blood pressure medications recalled due to cancer-causing chemical – WSOC TV
More than half a million bottles of a popular blood pressure medication have been recalled because they contain…
Cholesterol medication recalled over ‘failed dissolution specifications’: What to know
(NEXSTAR) – Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that…
More than 140,000 bottles of cholesterol medication part of elevated recall over health risk
A major recall of thousands of bottles of medication has been upgraded to a higher risk level. In…
Researchers say dangerous ‘Benadryl Challenge’ still active on TikTok
The “Benadryl challenge,” which started in 2020 on TikTok, is still active on social media platforms, despite the…
GLP-1 Weight-Loss Pills Could Transform Treatment
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy…
Apple Watch Adds FDA-Approved Blood Pressure Alerts Using AI
This article first appeared on GuruFocus. Apple (AAPL, Financials) is adding a new health feature to its Watch…
Do NAD and Peptides Work? The Anti-Aging Injection of the Moment
Like many men his age, William Stern was tired. At 45, the husband, father of three, and founder…
FDA Crackdown Flags Oprah Video and Drug Ad With Morgan Freeman
US regulators issued a flurry of letters calling out pharmaceutical companies for allegedly misleading ads, part of a…
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review…